GLP-1 receptor agonist delivery via prefilled syringe and autoinjector systems — the semaglutide, tirzepatide, and emerging incretin therapies requiring high-viscosity, large-volume subcutaneous administration representing the fastest-growing demand segment in the global prefilled syringe market — creates the most commercially dynamic device innovation pressure, with the Pre Filled...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
